Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Launch of Apple Music Keeps 'Planet Apple' Ahead of the Game - Cantor Fitzgerald (AAPL)
-
Apple (AAPL) Expands the Reach of 'Planet Apple' with Well Executed Apple Music Launch, Cantor Fitzgerald Says
-
Ocular Therapeutix™ to Participate at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Eagle Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference
-
Cantor Fitzgerald Remains Bullish on The Priceline Group (PCLN) Following Global Checks
-
Celgene (CELG) Deal With Juno (JUNO) 'Further Solidifies' Position in Oncology, Cantor Fitzgerald Says
-
Synergy Pharmaceuticals to Present at the Cantor Fitzgerald Healthcare Conference
-
Cantor Fitzgerald Europe Appoints Philip Dixon as Chief Operating Officer
-
DURECT to Present at the Cantor Fitzgerald Healthcare Conference
-
UPDATE: Cantor Fitzgerald Starts Intersect ENT (XENT) at Buy
-
Alimera Sciences To Present At Cantor Fitzgerald Inaugural Healthcare Conference
-
Zosano Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Zosano Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
ImmunoCellular Therapeutics to Present at Cantor Fitsgerald Inaugural Healthcare Conference on July 8th
-
Plateau Uranium Proposes to Issue Shares to Settle Debt
-
Everyday Health to Participate at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $50 at Cantor Fitzgerald
-
Cantor Fitzgerald's Fixed Income Team Expands with Senior Hires
-
Real Industry Announces At-the-Market Equity Offering Program
-
Glaukos Corporation Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Uranium Energy Corp Announces Closing of $10 Million Offering
-
Bio-Path Holdings Announces “At-the-Market” Offering with Cantor Fitzgerald
-
Glaukos Corporation (GKOS) IPO Opens Up 62%
-
Glaukos Corp. (GKOS) Prices 6M Common Stock IPO at $18/Share
-
Cantor Fitzgerald Remains Bullish on Expedia (EXPE) Following Industry Checks
-
Adamas Pharmaceuticals to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Adamas Pharmaceuticals to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
-
Progenics Pharmaceuticals to Present at Cantor Fitzgerald's Inaugural Healthcare Conference
-
Organovo Holdings, Inc. To Present at Cantor Fitzgerald Inaugural Healthcare Conference
-
Uranium Energy (UEC) Reports $10M in Financing
-
Uranium Energy Corp Announces a $10 Million Financing
-
Shutterstock (SSTK) Bullish Stance Reiterated at Cantor Fitzgerald Following 'Big Editorial Win'
-
Forget Taylor Swift, Apple (AAPL) Looking Great in China - Cantor Fitzgerald's White
-
Cantor Fitzgerald Expects StemCells (STEM) to Present GA Data This Week; Reiterates Buy
-
Notable Analyst Rating Changes 6/19: (EAC) (FISV) (EPE) Upgraded; (BMRN) (AIT) (BP) Downgraded
-
Cross Country Healthcare to Attend the Cantor Fitzgerald Healthcare Conference and Avondale Partners Healthcare 1-1 Conference
-
Cantor Fitzgerald Raised Price Target on Red Hat (RHT) Following 1Q16 Beat
-
Cantor Fitzgerald Downgrades Public Storage (PSA) to Hold
-
Cantor Fitzgerald Upgrades Sovran Self Storage (SSS) to Buy
-
Ligand Pharma (LGND) PT Raised to $93 at Cantor Fitzgerald
-
Makor Ranked #2 in EXTEL Survey
-
Organovo (ONVO) Prices 9.43M Common Stock Offering at $4.25/Share
-
Organovo Holdings, Inc. Prices $40 Million Public Offering of Common Stock
-
Cantor Fitzgerald Remains Bullish Following Oracle (ORCL) F4Q15 Results
-
Radius Health (RDUS) PT Lifted to $71 at Cantor Fitzgerald
-
Ligand to Participate in Four Upcoming Investor Conferences
-
Paratek Pharmaceuticals to Present at Upcoming Banking Conferences
-
Streetinsider.com's Hot Lunchtime Reads 6/17: (TWTR) (EEI) (VOD) (SGYP)
-
Synergy (SGYP) Seen as Attractive Takeout Target at Cantor Fitzgerald; PT Up to $14

